Clinico-Epidemiological Characteristics of Healthcare Workers with SARS-CoV-2 Infection during the First and Second Waves in a Teaching Hospital from Eastern India: A Comparative Analysis-Reference-Cited by-同舟云学术

Clinico-Epidemiological Characteristics of Healthcare Workers with SARS-CoV-2 Infection during the First and Second Waves in a Teaching Hospital from Eastern India: A Comparative Analysis

Published:2022-07-19 Issue: Volume: Page:1-12
ISSN:0018-5868
Container-title:Hospital Topics
language:en
Short-container-title:Hospital Topics

Author:

Singh Arvind Kumar¹^ORCID,Panigrahi Manoj Kumar²,Pradhan Somen Kumar¹^ORCID,Pal Debkumar¹,Subba Sonu H.¹^ORCID,Patro Binod Kumar¹,Behera Binod Kumar¹,Mishra Baijayantimala³,Behera Bijayini³^ORCID,Mohapatra Prasanta Raghab²,Bhuniya Sourin²,Bal Shakti Kumar²,Sarkar Saurav⁴,Pillai Jawahar S. K⁵,Mohanty Sachidananda⁶,Gitanjali Batmanabane⁶,

Affiliation:

1. Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences, Bhubaneswar, India

2. Department of Pulmonary Medicine & Critical Care, All India Institute of Medical Sciences, Bhubaneswar, India

3. Department of Microbiology, All India Institute of Medical Sciences, Bhubaneswar, India

4. Department of Ear Nose Throat, All India Institute of Medical Sciences, Bhubaneswar, India

5. Department of Hospital Administration, All India Institute of Medical Sciences, Bhubaneswar, India

6. All India Institute of Medical Sciences, Bhubaneswar, India

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00185868.2022.2096523

Reference37 articles.

1. Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines

2. Effectiveness of COVID-19 vaccine (Covaxin) against breakthrough SARS-CoV-2 infection in India

3. Patient Characteristics and Clinical Course of COVID-19 Patients Treated at a German Tertiary Center during the First and Second Waves in the Year 2020

4. COVID-19 Vaccine Breakthrough Infections Reported to CDC — United States, January 1–April 30, 2021

5. Centres for Disease Control and Prevention. Common investigation protocol for investigating suspected SARS CoV-2 reinfection. Accessed November 25, 2021. https://www.cdc.gov/coronavirus/2019-ncov/php/reinfection.html